Cash Flow Statement
Growth Metrics

Bio Key International (BKYI) Debt to Equity (2019 - 2025)

Bio Key International (BKYI) has disclosed Debt to Equity for 11 consecutive years, with $0.18 as the latest value for Q3 2025.

  • Quarterly Debt to Equity fell 89.39% to $0.18 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $0.18 through Sep 2025, down 89.39% year-over-year, with the annual reading at $0.04 for FY2024, 80.18% down from the prior year.
  • Debt to Equity hit $0.18 in Q3 2025 for Bio Key International, up from $0.02 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $1.7 in Q3 2024 to a low of -$0.74 in Q3 2023.
  • Historically, Debt to Equity has averaged $0.16 across 4 years, with a median of $0.07 in 2022.
  • Biggest YoY gain for Debt to Equity was 385.83% in 2023; the steepest drop was 1101.64% in 2023.
  • Year by year, Debt to Equity stood at $0.08 in 2022, then skyrocketed by 110.63% to $0.18 in 2023, then plummeted by 80.18% to $0.04 in 2024, then skyrocketed by 411.54% to $0.18 in 2025.
  • Business Quant data shows Debt to Equity for BKYI at $0.18 in Q3 2025, $0.02 in Q2 2025, and $0.02 in Q1 2025.